Combination of machine learning-based bulk and single-cell genomics reveals necroptosis-related molecular subtypes and immunological features in autism spectrum disorder
Source check: Source checked. Not independent scientific confirmation.
Finding: The article reports necroptosis-associated molecular subgroups and a candidate four-gene signature in ASD; the retrospective result does not establish causal subtypes or clinical benefit. Two GEO datasets and peripheral-blood RT-PCR are reported as validation; the paper notes limited performance/sample evidence and need for larger cohorts.
Technology: LASSO, random-forest feature selection and SVM-RFE are used to identify candidate genes and build subgroup/signature analyses.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LASSO, random-forest feature selection and SVM-RFE are used to identify candidate genes and build subgroup/signature analyses.
- Test and result
- The article reports necroptosis-associated molecular subgroups and a candidate four-gene signature in ASD; the retrospective result does not establish causal subtypes or clinical benefit.
- Limitation / still unknown
- Two GEO datasets and peripheral-blood RT-PCR are reported as validation; the paper notes limited performance/sample evidence and need for larger cohorts.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1139420/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.